Bioinformatics Grid Application for life science

The European Commission promotes the Bioinformatics Grid Application for life science (BioinfoGRID) project. The project aims to connect many European computer centres in order to carry out Bioinformatics research and to develop new applications in the sector using a network of services based on futuristic Grid networking technology that represents the natural evolution of the Web.

More specifically the BioinfoGRID project will make research in the fields of Genomics, Proteomics, Transcriptomics and applications in Molecular Dynamics much easier, reducing data calculation times thanks to the distribution of the calculation at any one time on thousands of computers across Europe and the world.

Furthermore it will provide the possibility of accessing many different databases and hundreds of applications belonging to thousands of European users by exploiting the potential of the Grid infrastructure created with the EGEE European project and coordinated by CERN in Geneva.

The BioinfoGRID project foresees an investment of over one million euros funded through the European Commission's "Research Infrastructures" budget. Grid networking promises to be a very important step forward in the Information Technology field. Grid technology will make a global network made up of hundreds of thousands of interconnected computers possible, allowing the shared use of calculating power, data storage and structured compression of data. This goes beyond the simple communication between computers and aims instead to transform the global network of computers into a vast joint computational resource.

Grid technology is a very important step forward from the Web, that simply allows the sharing of information over the internet. The massive potential of Grid technology will be indispensable when dealing with both the complexity of models and the enormous quantity of data, for example, in searching the human genome or when carry out simulations of molecular dynamics for the study of new drugs.

For further information, please visit:
The BioinfoGRID Project Potal

Most Popular Now

Researchers Capture First Images of Oxyg…

Oxygen in cancer tumors is known to be a major factor that helps radiation therapy be successful. Hypoxia, or starvation of oxygen, in solid tumors is also thought to be...

VTT Makes New Investments in Digital Hea…

VTT is launching new research activities in the area of digital health as part of the growing wellbeing and health technology ecosystem in Kuopio. The new initiative aims to create...

A New Method of Artificial Intelligence …

Despite the immense progress in the field of AI in recent years, we are still very far from human intelligence. Indeed, if current AI techniques allow to train computer agents...

FDA Informs Health Care Providers, Facil…

Today, the U.S. Food and Drug Administration is issuing a safety communication informing health care providers, facilities and patients about cybersecurity vulnerabilities identified for certain GE Healthcare Clinical Information Central...

eHealthWeek 2020 Croatia - Trusted Infor…

15 - 17 April 2020, Rovinj, Croatia. In its capacity of hosting the upcoming Presidency of the Council of the European Union, the Croatian Ministry of Health is in preparations to...

Siemens Healthineers Presents Solutions …

CT scanners with intelligent user guidance, AI-based software assistants for MRI and a lab system that revolutionizes workflows: Siemens Healthineers is showcasing its products and solutions according to the motto...

NHS IT Chiefs Set the Stage for a Year o…

3 - 4 March 2019, London, United Kingdom. NHS technology leaders are to kick off the second-ever Digital Health Rewired Conference and Exhibition on 3 - 4 March at the Olympia...

PatchAi Startup has Arrived in the Marke…

PatchAi - a startup that offers, thanks to Artificial Intelligence and Machine Learning, an empathic virtual assistant to patients participating in clinical trials - announced that it has closed two...

Digital Health App Medicus AI Earns CE C…

Medicus AI, the Vienna-based health tech company, has received a ​Class I Medical Device CE Mark for its mobile application. The CE certification mark confirms that Medicus AI conforms to...

Refining Breast Cancer Classification by…

Breast cancer progression can vary significantly between patients. Even within the same tumor, different areas may be composed of different types of cells and characterized by different tumor structures. This...

Human Body-on-Chip Platform Enables In V…

Drug development is an extremely arduous and costly process, and failure rates in clinical trials that test new drugs for their safety and efficacy in humans remain very high. According...

FDA Authorizes Marketing of First Cardia…

Today, the U.S. Food and Drug Administration authorized marketing of software to assist medical professionals in the acquisition of cardiac ultrasound, or echocardiography, images. The software, called Caption Guidance, is...